Cyclease Cramps Tablet
FDA Label NDC 0220-9078

17 label sections · Submitted to the FDA by Laboratoires Boiron · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Laboratoires Boiron for the product Cyclease Cramps (NDC 0220-9078). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, indications & usage, otc - do not use, dosage & administration, inactive ingredient, how supplied, otc - purpose, storage and handling, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Do Not Use

Do not use if glued carton en flaps are open or if the blister seal is broken

Inactive Ingredient

Croscarmellose sodium, lactose, magnesium stearate

How Supplied

60 tablets

Storage And Handling

Store at 68-77 o F

Otc - Ask Doctor


Otc - Stop Use

Stop use and ask a doctor if symptoms persist for more than 7 days or worsen.

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Otc - When Using


Drug Interactions

Safe - no side effects - no drug interactions - works naturally with your body

* Please review the disclaimer below.